ARK Investment Management INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 26 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

ARK Investment Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$439,003
-32.7%
9,514,580
+5.9%
2.60%
-4.7%
Q1 2022$652,651
-30.3%
8,981,029
+13.4%
2.72%
-3.7%
Q4 2021$936,092
+3.5%
7,916,882
+17.4%
2.83%
+30.3%
Q3 2021$904,648
-27.3%
6,743,556
-12.2%
2.17%
-6.2%
Q2 2021$1,244,188
+61.3%
7,684,441
-20.1%
2.32%
+51.1%
Q1 2021$771,404
+26.7%
9,611,911
-14.1%
1.53%
-5.4%
Q4 2020$608,827
+168.5%
11,191,670
-1.9%
1.62%
+20.4%
Q3 2020$226,726
-5.4%
11,404,752
+0.0%
1.34%
-47.8%
Q2 2020$239,699
+91.4%
11,403,379
+11.4%
2.58%
-17.4%
Q1 2020$125,226
-2.3%
10,239,286
+17.1%
3.12%
-3.5%
Q4 2019$128,237
+13.4%
8,741,432
+3.2%
3.23%
+31.0%
Q3 2019$113,082
-16.2%
8,470,576
+2.8%
2.47%
-27.4%
Q2 2019$134,941
-1.0%
8,243,165
+3.3%
3.40%
-12.7%
Q1 2019$136,319
+46.8%
7,981,198
+17.3%
3.90%
+3.3%
Q4 2018$92,847
-43.6%
6,801,952
+18.2%
3.77%
-24.2%
Q3 2018$164,673
+33.3%
5,753,790
+27.5%
4.98%
+10.0%
Q2 2018$123,492
+62.5%
4,513,584
+25.3%
4.52%
+19.9%
Q1 2018$75,987
+187.5%
3,602,976
+162.0%
3.77%
+79.2%
Q4 2017$26,430
+844.9%
1,375,149
+686.7%
2.10%
+286.2%
Q2 2017$2,797
+148.6%
174,810
+118.9%
0.54%
+68.2%
Q1 2017$1,125
+223.3%
79,850
+200.8%
0.32%
+155.1%
Q4 2016$34826,5440.13%